Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy
Nano Letters · 04.02.2026 · 26 (4) · 1181-1191
DOI: 10.1021/acs.nanolett.5c04420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 20.10.2025. Verfasst von Ya-Ning Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Health Sciences, Northeastern University, Shenyang, P. R. China, 110819. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Carbazoles, Complement C1q. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, Natural Science Foundation of Top Talent of SZTU, Liaoning Provincial Department of Education Funding.
Themen: Demenz
Abstract (Originalsprache)
Aberrant activation of the complement system drives early synaptic loss and chronic neuroinflammation in Alzheimer's disease (AD). Here, we identified complement component C1q as a key upregulated target in AD and screened Alectinib (ALE), an FDA-approved kinase inhibitor, as a high-affinity C1q binder. To achieve brain-targeted delivery, ALE was encapsulated in nanostructured lipid carriers camouflaged with microglial membranes (ALE@MM-NLCs). This biomimetic design enhanced blood-brain barrier (BBB) penetration and microglial uptake. In APP/PS1 mice, ALE@MM-NLCs improved cognitive performance and reduced C1q expression, β-amyloid (Aβ) burden, and glial activation, while promoting microglial M2-like polarization. Mechanistically, ALE@MM-NLCs suppressed oxidative stress, NLRP3 inflammasome activation, and C1q-mediated synaptosome phagocytosis, thereby preventing proteasome-dependent synaptic degradation. These results highlight ALE@MM-NLCs as a promising immunomodulatory nanotherapy for synaptic preservation and early AD intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life and Health Sciences, Northeastern University, Shenyang, P. R. China, 110819.
- College of Pharmacy, Shenzhen Technology University, Shenzhen, P. R. China, 518118.
ORCID-Profile: Pu Wang
Förderung
- Shenzhen Medical Research Fund
- Natural Science Foundation of Top Talent of SZTU
- Liaoning Provincial Department of Education Funding
- Shenzhen Technology University
- Department of Education of Liaoning Province
Zitieren
APA
Ding, Y. N., Li, M. Q., Ding, P. T., Wang, P., & Guan, P. P. (2026). Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy. Nano Letters, 26(4), 1181-1191. https://doi.org/10.1021/acs.nanolett.5c04420
Vancouver
Ding YN, Li MQ, Ding PT, Wang P, Guan PP. Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy. Nano Letters. 2026;26(4):1181-1191. doi:10.1021/acs.nanolett.5c04420
BibTeX
@article{Ding2026,
author = {Ding, Ya-Ning and Li, Mei-Qi and Ding, Ping-Tian and Wang, Pu and Guan, Pei-Pei},
title = {Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer’s Disease: A Bioinspired Alectinib Delivery Strategy},
journal = {Nano Letters},
year = {2026},
volume = {26},
number = {4},
pages = {1181--1191},
doi = {10.1021/acs.nanolett.5c04420}
}
EUVIMED